The pharmaceutical industry is highly regulated, ensuring that all drugs are safe, effective, and properly labeled. One of the key components in this regulatory framework is the National Drug Code (NDC). Understanding what an NDC labeler code is and how it fits into the broader context of drug compliance is essential for anyone involved in the pharmaceutical sector.

Understanding the NDC Labeler Code

The National Drug Code (NDC) is a unique identifier for medicines intended for human use. It is a crucial part of the drug registration and listing process with the FDA. The NDC is a 10- or 11-digit number divided into three segments:

  1. Labeler Code: The first segment, assigned by the FDA, identifies the company that manufactures, repackages, or distributes the drug. This is known as the NDC labeler code.
  2. Product Code: The second segment identifies the specific strength, dosage form, and formulation of the drug.
  3. Package Code: The final segment identifies the package size and type.

For example, an NDC of 12345-6789-01 might be broken down as follows:

  • 12345: Labeler code (identifying the manufacturer or distributor)
  • 6789: Product code (specific to the drug formulation)
  • 01: Package code (specific to the packaging)

The NDC labeler code is vital as it ensures traceability and accountability in the drug supply chain. It helps healthcare professionals, pharmacists, and regulatory bodies identify and track pharmaceuticals.

The Importance of Compliance with NDC Labeler Code Requirements

Compliance with NDC regulations is non-negotiable for pharmaceutical companies. Non-compliance can lead to severe consequences, including product recalls, fines, and legal action. Ensuring that the NDC is accurate and up-to-date is essential for maintaining market access and avoiding regulatory penalties.

How EMMA International Can Help

EMMA International is a leader in providing compliance and quality solutions for the life sciences industry. They offer a range of services that can help pharmaceutical companies navigate the complexities of NDC labeler code requirements and broader regulatory compliance.

  1. Regulatory Consulting: EMMA International provides expert guidance on FDA regulations, including the intricacies of NDC registration and listing. Their team of professionals can help ensure that your NDC submissions are accurate and compliant with FDA requirements.
  2. Quality Management Systems (QMS): EMMA International assists in developing and implementing robust QMS that encompass all aspects of drug manufacturing and distribution, ensuring that NDC labeler code compliance is integrated into your quality processes.
  3. Training and Education: Understanding the regulatory landscape is crucial for all team members involved in the pharmaceutical supply chain. EMMA International offers training programs to educate your staff on the importance of NDC labeler codes and how to maintain compliance.
  4. Audit Services: Regular audits are essential to ensure ongoing compliance. EMMA International conducts thorough audits to identify potential gaps in your processes and provide actionable recommendations to address any issues related to NDC labeler codes and other regulatory requirements.

The NDC labeler code is a critical component of pharmaceutical regulation, ensuring that drugs are properly identified and traceable. Compliance with NDC regulations is essential for pharmaceutical companies to avoid regulatory issues and maintain market access. EMMA International’s comprehensive services in regulatory consulting, quality management, training, and auditing can help your organization stay compliant with NDC labeler code requirements and navigate the complex landscape of pharmaceutical regulations. Partnering with experts like EMMA International can provide peace of mind and allow you to focus on what you do best – delivering safe and effective pharmaceuticals to the market.

To learn more call 248-987-4497 or email info@emmainternational.com.

FDA (March 2017) National Drug Code Database Background Information retrieved from: https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information#:~:text=NDC%20Number,-Each%20listed%20drug&text=This%20number%2C%20known%20as%20the,its%20own%20name)%20the%20drug.

EMMA International

EMMA International

EMMA International Consulting Group, Inc. is a global leader in FDA compliance consulting. We focus on quality, regulatory, and compliance services for the Medical Device, Combination Products, and Diagnostics industries.

More Resources

Advances in Oncology

Advances in Oncology

AstraZeneca and Daiichi Sankyo are advancing their oncology collaboration with promising data for their ...

Ready to learn more about working with us?

Pin It on Pinterest

Share This